Sep 30 2024 18 mins
Visit https://www.peervoice.com/XJN860 to view the entire programme with slides. After completing “Simron Singh, MD, MPH - Addressing the Challenges of Treating Highly Proliferative Neuroendocrine Tumours: Review of the Latest Evidence”, participants will be able to: Discuss the benefits and limitations of current therapeutic management of G2 and G3 advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs); Identify emerging treatment strategies for patients with G2 and G3 advanced GEP-NETs; and Translate the clinical data for emerging treatment strategies for G2 and G3 advanced GEP-NETs in context of current unmet needs.